orphan drug market
Orphan Drugs are Forerunners of Personalised Medicine
October 20 by Cristina FalcãoMarketing exclusivity in EU and U.S.A provided a monopolistic market for orphan drugs without “me-too”/generics competitors, to pharma companies. Orphan drug laws and the pharma indus...
Are Orphan Disease Areas Orphaned?
August 02 by Pharma IQ NewsLeading biopharmaceutical research consultancy Medical Marketing Research Group (MMR Group) has successfully completed two major orphan drug Opinion Leader identification projects for two of the wor...
Are Orphan Drugs Still a Licence to Print Money?
July 20 by Andrea CharlesIn this podcast Donald Macarthur, global pharmaceutical business analyst, speaks to Andrea Charles from Pharma IQ, about Pharma's steps into the orphan drug market and whether payers can afford to fun...
